Skip to main content
logo
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
46.68
+0.92 (2.01%)
May 7, 2026, 10:11 AM EDT - Market open

Novo Nordisk Revenue by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
214.33B213.12B211.73B206.62B198.11B192.75B182.45B173.47B
Diabetes Growth
8.19%10.57%16.05%19.11%22.93%24.59%23.92%24.31%
Obesity
81.31B79.00B72.54B65.15B54.97B48.42B44.83B41.63B
Obesity Growth
47.92%63.15%61.82%56.48%53.16%73.14%110.41%146.87%
Rare Disease
19.96B19.82B18.87B18.64B17.51B16.83B16.97B17.16B
Rare Disease Growth
14.05%17.73%11.21%8.60%0.34%-9.75%-14.09%-16.45%

Operating Income by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
131.44B140.70B134.75B127.72B117.71B110.96B106.68B99.62B
Diabetes and Obesity Care Growth
11.67%26.80%26.31%28.20%29.95%35.29%41.90%47.82%
Rare Disease
1.22B2.10B536.00M620.00M661.00M504.00M2.74B2.95B
Rare Disease Growth
83.81%317.46%-80.40%-78.99%-71.50%-87.86%-50.18%-60.20%

Revenue by Geography

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
183.79B185.24B183.21B178.17B165.43B157.88B146.61B136.63B
North America Growth
11.10%17.33%24.96%30.41%37.09%44.35%46.01%49.97%
International
131.82B126.70B119.93B112.23B105.15B100.12B97.63B95.63B
International Growth
25.36%26.54%22.84%17.36%12.08%8.89%11.10%11.40%
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.